Showing results (401-410 of 486) with videos related to
Sort By:
Pageof 49
Urology|June 14, 2022
Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCGTakamitsu Inoue, Makito Miyake, Nobutaka Nishimura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|October 6, 2023
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territoriesJa Hyeon Ku, Lui Shiong Lee, Tzu-Ping Lin, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|October 5, 2023
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-PacificEiji Kikuchi, Chi-Fai Ng, Hiroshi Kitamura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancerYasukiyo Murakami, Kazumasa Matsumoto, Makito Miyake, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 24, 2025
Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate CancerHiroki Hagimoto, Shinichi Sakamoto, Kodai Sato, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 21, 2026
Consensus-Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic OncologyRikiya Taoka, Nozomi Hayakawa, Tomokazu Kimura, et al.International Journal of Clinical Oncology|July 27, 2021
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomyKota Iida, Makito Miyake, Kaoru Murakami, et al.Nature Biotechnology|October 24, 2007
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal regionFumihiko Ishikawa, Shuro Yoshida, Yoriko Saito, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 12, 2025
Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical Bacillus Calmette-Guérin (BCG) Therapy in BCG-Naïve or -Unresponsive Non-Muscle-Invasive Bladder CancerMakito Miyake, Nobutaka Nishimura, Rikiya Taoka, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective StudyNaoki Fujita, Yuto Matsushita, Takahiro Kojima, et al.Pageof 49